Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
Background and purpose: FXR is a promising target for the treatment of human cholestatic liver disease (CLD). SIRT1 is a deacetylase which promotes FXR activity through deacetylating FXR. Pterostilbene (PTE) is an activator of SIRT1. However, the role of PTE in cholestasis has so far not been invest...
Saved in:
Main Authors: | Chuanrui Ma (Author), Jiaqing Xiang (Author), Guixiao Huang (Author), Yaxi Zhao (Author), Xinyu Wang (Author), Han Wu (Author), Kewei Jiang (Author), Zhen Liang (Author), Lin Kang (Author), Guangyan Yang (Author), Shu Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease
by: Xinyu Wang, et al.
Published: (2021) -
Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation
by: Chuanrui Ma, et al.
Published: (2022) -
MicroRNA‐92b in the skeletal muscle regulates exercise capacity via modulation of glucose metabolism
by: Shu Yang, et al.
Published: (2023) -
KLF13 restrains Dll4‐muscular Notch2 axis to improve the muscle atrophy
by: Shu Yang, et al.
Published: (2024) -
Pterostilbene alleviates pulmonary fibrosis by regulating ASIC2
by: Yanfang Peng, et al.
Published: (2021)